BR0309114A - Uso de carboidratos derivados particulados em composições farmacêuticas em pó seco, composição farmacêutica em pó seco para terapia de inalação, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, e, embalagem de medicamento - Google Patents
Uso de carboidratos derivados particulados em composições farmacêuticas em pó seco, composição farmacêutica em pó seco para terapia de inalação, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, e, embalagem de medicamentoInfo
- Publication number
- BR0309114A BR0309114A BR0309114-7A BR0309114A BR0309114A BR 0309114 A BR0309114 A BR 0309114A BR 0309114 A BR0309114 A BR 0309114A BR 0309114 A BR0309114 A BR 0309114A
- Authority
- BR
- Brazil
- Prior art keywords
- dry powder
- powder pharmaceutical
- pharmaceutical composition
- treatment
- inhalation
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 6
- 239000000843 powder Substances 0.000 title abstract 5
- 238000011282 treatment Methods 0.000 title abstract 3
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 235000014633 carbohydrates Nutrition 0.000 title abstract 2
- 238000002664 inhalation therapy Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000009512 pharmaceutical packaging Methods 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0208608.0A GB0208608D0 (en) | 2002-04-13 | 2002-04-13 | Composition |
| PCT/GB2003/001542 WO2003088943A1 (en) | 2002-04-13 | 2003-04-10 | Dry powder compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0309114A true BR0309114A (pt) | 2005-02-01 |
Family
ID=9934855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0309114-7A BR0309114A (pt) | 2002-04-13 | 2003-04-10 | Uso de carboidratos derivados particulados em composições farmacêuticas em pó seco, composição farmacêutica em pó seco para terapia de inalação, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, e, embalagem de medicamento |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20050244340A1 (enExample) |
| EP (1) | EP1494644A1 (enExample) |
| JP (1) | JP2005530733A (enExample) |
| KR (1) | KR20040099436A (enExample) |
| CN (1) | CN1658839A (enExample) |
| AR (1) | AR039409A1 (enExample) |
| AU (1) | AU2003217073A1 (enExample) |
| BR (1) | BR0309114A (enExample) |
| CA (1) | CA2481467A1 (enExample) |
| GB (1) | GB0208608D0 (enExample) |
| IL (1) | IL164420A0 (enExample) |
| IS (1) | IS7500A (enExample) |
| MX (1) | MXPA04010080A (enExample) |
| NO (1) | NO20044497L (enExample) |
| PL (1) | PL373294A1 (enExample) |
| RU (1) | RU2004130439A (enExample) |
| TW (1) | TW200404008A (enExample) |
| WO (1) | WO2003088943A1 (enExample) |
| ZA (1) | ZA200408245B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005507881A (ja) | 2001-09-17 | 2005-03-24 | グラクソ グループ リミテッド | 乾燥粉末医薬製剤 |
| SE526509C2 (sv) * | 2003-06-19 | 2005-09-27 | Microdrug Ag | Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd |
| JP2009513529A (ja) * | 2003-07-11 | 2009-04-02 | グラクソ グループ リミテッド | ステアリン酸マグネシウムを含む医薬製剤 |
| EP1643974A1 (en) * | 2003-07-11 | 2006-04-12 | Glaxo Group Limited | Inhalable pharmaceutical formulations comprising a sugar ester |
| AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
| WO2006066907A1 (en) * | 2004-12-21 | 2006-06-29 | Glaxo Group Limited | Pharmaceutical formulations |
| NZ556709A (en) * | 2005-02-10 | 2009-09-25 | Glaxo Group Ltd | Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| JP2009545579A (ja) | 2006-08-01 | 2009-12-24 | グラクソ グループ リミテッド | ピラゾロ［３，４−ｂ］ピリジン化合物、及びｐｄｅ４阻害薬としてのその使用 |
| GB0921075D0 (en) * | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| CN105324107A (zh) * | 2013-04-29 | 2016-02-10 | 赛诺菲股份有限公司 | 可吸入药用组合物和含有该药用组合物的吸入器装置 |
| AU2015296024A1 (en) * | 2014-08-01 | 2017-03-23 | Luxena Pharmaceuticals, Inc. | Palonosetron formulations and uses thereof |
| PT109030B (pt) * | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
| CN110237373B (zh) * | 2018-03-08 | 2023-06-02 | 润生药业有限公司 | 一种生产用于联合用药的药物载体的装置及方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR8007911A (pt) * | 1979-12-06 | 1981-06-16 | Glaxo Group Ltd | Inalador aperfeicoado |
| SE448277B (sv) * | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
| FI88112C (fi) * | 1985-07-30 | 1993-04-13 | Glaxo Group Ltd | Anordning foer administrering av laekemedel till patienter |
| GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| JPH04220268A (ja) * | 1990-12-19 | 1992-08-11 | Olympus Optical Co Ltd | バルーンカテーテル |
| ZA9711732B (en) * | 1996-12-31 | 1998-12-28 | Quadrant Holdings Cambridge | Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery |
| DE69809746T2 (de) * | 1997-07-03 | 2004-09-30 | Elan Drug Delivery Ltd., Ruddington | Modifiziere glykoside, modifizierte glyckoside enthaltende zusammensetzungen und verfahren zu ihrer herstellung |
| US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
| HU226164B1 (en) * | 1998-11-13 | 2008-05-28 | Jagotec Ag | Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation |
| GB9916316D0 (en) * | 1999-07-12 | 1999-09-15 | Quadrant Holdings Cambridge | Dry powder compositions |
| GB0015981D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
| GB0020616D0 (en) * | 2000-08-21 | 2000-10-11 | Quadrant Holdings Cambridge | Particulates |
| WO2002043750A2 (en) * | 2000-12-01 | 2002-06-06 | Battelle Memorial Institute | Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| GB0103630D0 (en) * | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-04-13 GB GBGB0208608.0A patent/GB0208608D0/en not_active Ceased
-
2003
- 2003-04-10 AU AU2003217073A patent/AU2003217073A1/en not_active Abandoned
- 2003-04-10 RU RU2004130439/15A patent/RU2004130439A/ru not_active Application Discontinuation
- 2003-04-10 PL PL03373294A patent/PL373294A1/xx not_active Application Discontinuation
- 2003-04-10 EP EP03712461A patent/EP1494644A1/en not_active Withdrawn
- 2003-04-10 WO PCT/GB2003/001542 patent/WO2003088943A1/en not_active Ceased
- 2003-04-10 JP JP2003585695A patent/JP2005530733A/ja active Pending
- 2003-04-10 CA CA002481467A patent/CA2481467A1/en not_active Abandoned
- 2003-04-10 BR BR0309114-7A patent/BR0309114A/pt not_active IP Right Cessation
- 2003-04-10 US US10/511,042 patent/US20050244340A1/en not_active Abandoned
- 2003-04-10 CN CN038137194A patent/CN1658839A/zh active Pending
- 2003-04-10 KR KR10-2004-7016302A patent/KR20040099436A/ko not_active Withdrawn
- 2003-04-10 MX MXPA04010080A patent/MXPA04010080A/es unknown
- 2003-04-11 TW TW092108394A patent/TW200404008A/zh unknown
- 2003-04-11 AR ARP030101280A patent/AR039409A1/es not_active Application Discontinuation
-
2004
- 2004-10-05 IL IL16442004A patent/IL164420A0/xx unknown
- 2004-10-11 IS IS7500A patent/IS7500A/is unknown
- 2004-10-12 ZA ZA200408245A patent/ZA200408245B/xx unknown
- 2004-10-21 NO NO20044497A patent/NO20044497L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1658839A (zh) | 2005-08-24 |
| US20050244340A1 (en) | 2005-11-03 |
| RU2004130439A (ru) | 2005-06-10 |
| KR20040099436A (ko) | 2004-11-26 |
| IL164420A0 (en) | 2005-12-18 |
| IS7500A (is) | 2004-10-11 |
| GB0208608D0 (en) | 2002-05-22 |
| CA2481467A1 (en) | 2003-10-30 |
| WO2003088943A1 (en) | 2003-10-30 |
| AR039409A1 (es) | 2005-02-16 |
| AU2003217073A1 (en) | 2003-11-03 |
| EP1494644A1 (en) | 2005-01-12 |
| NO20044497L (no) | 2004-11-15 |
| ZA200408245B (en) | 2007-03-28 |
| TW200404008A (en) | 2004-03-16 |
| JP2005530733A (ja) | 2005-10-13 |
| PL373294A1 (en) | 2005-08-22 |
| MXPA04010080A (es) | 2004-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309115A (pt) | Composição farmacêutica em pó seco, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, embalagem de medicamento, e, uso de carboidratos derivados particulados em composição farmacêutica em pó seco | |
| BR0309114A (pt) | Uso de carboidratos derivados particulados em composições farmacêuticas em pó seco, composição farmacêutica em pó seco para terapia de inalação, método de tratamento ou profilaxia de distúrbios respiratórios, uso de uma composição farmacêutica em pó seco, dispositivo de inalação, e, embalagem de medicamento | |
| TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
| BR0110139A (pt) | Formulações farmacêuticas para inaladores de pó seco | |
| BG102689A (bg) | Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения | |
| DE69005951D1 (de) | Medikamente enthaltend Salmeterol und Fluticason. | |
| AR015820A1 (es) | Particulas de budesonida, composicion farmaceutica, uso de dichas particulas para la fabricacion de medicamentos, metodo para el tratamiento de untrastorno respiratorio y proceso para la preparacion de las particulas | |
| CY1106430T1 (el) | Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο | |
| WO2005041921A3 (en) | Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor | |
| BR9406907A (pt) | Preparação terapêutica uso da mesma dispositivo inalador de pó seco inalador de pó seco e uso de um agente de melhoramento na preparação de uma preparação de pó seco inalavel | |
| SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| PT1326595E (pt) | Composicao farmaceutica compreendendo resveratrol para o tratamento de disturbios respiratorios inflamatorios | |
| BR0008699A (pt) | Combinações de formoterol e furoato demometasona para asma | |
| BR0214806A (pt) | Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno | |
| BR0107983A (pt) | Uso de pramipexol para o tratamento de enfermidades decorrentes de vìcios | |
| DE69002718D1 (de) | Medikamente. | |
| DE60135099D1 (de) | Pulverinhalator | |
| BRPI0509026A (pt) | formulação de aerossol, método para a prevenção e tratamento de infecção causada por bactéria do trato respiratório, e, solução | |
| BRPI0408744A (pt) | 4-feniltetrahidroisoquinolinas substituìdas, processos para preparação das mesmas, seu uso como medicamento, bem como medicamento que contém as mesmas | |
| BR0311747A (pt) | Composição farmacêutica, forma de dose simples ou de múltiplas doses da composição, kit, e, método para tratar doença | |
| DE69918961D1 (de) | Verbesserte inhalationspräparate | |
| BR0010006A (pt) | Utilização do saredutante e de seus sais farmaceuticamente aceitáveis para o preparo de medicamentos úteis no tratamento ou na prevenção do conjunto das perturbações do humor, das perturbações da adaptação ou das perturbações mistas ansiedade-depressão | |
| PL2253312T3 (pl) | Zastosowanie osmolitów uzyskiwanych z bakterii ekstremofilnych do wytwarzania wziewnych środków leczniczych do profilaktyki i leczenia chorób płucnych i sercowo-naczyniowych oraz urządzenie do inhalacji zawierające osmolity jako składnik czynny | |
| NO20051463L (no) | Inhaleringssammensetninger med hoy legemiddelandel | |
| WO2005041922A3 (en) | Composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE A 8.6 DA RPI 2116 DE 26/07/2011. |